“…However, implantation of biomaterials is followed by blood–material interaction, which leads to protein adsorption that can initiate an inflammatory cascade comprising injury, followed by acute and chronic inflammation, formation of granulation tissue, foreign body response, and eventually fibrous encapsulation. This represents in the majority of cases an undesired event and is largely influenced by the characteristics of the implanted biomaterials, such as surface properties and compliance and shape (Vasconcelos, Águas, Barbosa, Pelegrín, & Barbosa, ; Velnar, Bunc, Klobucar, & Gradisnik, ). Macrophages play a significant role in the inflammation process and are considered as key effector and dominant cells secreting pro‐inflammatory cytokines such as IL‐1β and tumour necrosis factor‐α (TNFα), chemokines and growth factors, such as monocyte chemoattracting protein 1 (MCP‐1), transforming growth factor‐β, and platelet‐derived growth factor (Oishi & Manabe, ; Wynn & Vannella, ).…”